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ABSTRACT 
The adrenal gland is exposed to high concentrations of circulating xenobiotics due to its high 
rate of blood flow and it may also accumulate lipid soluble chemicals in its lipid rich tissue. 
These substances can affect the aldosterone synthesis in the glomerulosa cells by activation or 
suppression of the steroidogenic enzymes’ gene expression, hence resulting in effects on 
blood pressure since this is the main action of aldosterone. 
 The purpose of this project was to set up a model system for detection of xenobiotic effects 
on aldosterone synthesis due to changes in gene expression of involved enzymes and 
transporter proteins. The human adrenocarcionoma cell line H295R was subjected to 
angiotensin II (ang II) and potassium acetate (KAc), in order to establish which modulator 
that most efficiently differentiates the cells into glomerulosa like aldosterone secreting cells. 
Further the cells were tested for differences in differentiation due to various time intervals and 
for Ultroser SF (USF) supplementation in the medium. Leads effect on the involved genes in 
aldosterone formation was investigated, since lead is a known activator of aldosterone 
secretion. 
 The results indicated that ang II was the best modulator for differentiating the cells, KAc 
had cytotoxic effects at higher concentrations. The results also indicated that USF 
supplementation in the medium had a rising effect on basal gene transcription levels of the 
steroidogenic enzymes, some genes differed as much as 70-fold in expression levels between 
the two medium types. USF- medium was therefore chosen for exposure experiments, since 
the chemical effect hence became clearer. 
 The lead exposures indicated that this substance did not affect the gene expression level of 
the investigated genes, except for small effects in medium without USF and ang II. Some 
other differences in gene expression were noted between the control and the samples, but they 
were very small even if they were statistically significant.  
 The model will need more testing with other substances and the aldosterone level during 
chemical exposure will need to be determined. We have so far established that ang II is an 
efficient stimulator of glomerulosa like differentiation and that USF- medium is favorable in 
the experiments. 
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ABBREVIATIONS 
12-LO 12-lipoxygenase 
3β-HSD 3β-hydroxysteroid dehydrogenase 
ACTH adrenocorticotropic hormone 
Ang II angiotensin II 
AT1R angiotensin type I receptor 
ATF activating transcription factor 
CRAC calcium relese activated channels 
CRE cAMP response element, same as Ad1 
CREB CRE-binding protein 
CYP11A1 side-chain cleavage cytochrome P450, P450SCC 
CYP11B1 11β-hydroxylase 
CYP11B2 aldosterone synthase 
CYP17A1 17α-hydroxylase 
CYP21A2 21-hydroxylase 
DAG sn-1,2-diacylglycerol 
ER endoplasmatic reticulum 
IP3 inositol 1,4,5-triphosphate 
KAc potassium acetate 
MEK mitogen-activated protein kinases kinase 
PKA protein kinase A 
PKC protein kinase C 
PLC phospholipase C 
QRT-PCR quantitative real time polymerase chain reaction 
SF-1 steroidogenic factor-1 
StAR steroidogenic acute regulatory protein 
USF Ultroser SF (serum replacement) 
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1. INTRODUCTION 
It has been shown that there is often variable species responsiveness to chemical toxicity. 
Laboratory animals are usually used in order to assess toxic effects of xenobiotic chemicals in 
humans (Klaassen, 2001). Due to the interspecies difference it is of interest to establish a 
model more suitable for humans than using laboratory animals.  
 In this project the human adrenocarcinoma cell line H295R, was used to set up a model 
system for testing the gene expression effects of different substances i.e. drugs, pesticides and 
other xenobiotics on aldosterone production in the human adrenal gland. 
 
1.1 The adrenal gland 
The adrenal gland is a relatively small organ located above the upper pole of each kidney. It 
has a weight of 4-10 g (Boron and Boulpaep, 2003; Nussey and Whitehead, 2001; Berne et 
al., 1998) and one of the body’s highest rates of blood flow per gram of tissue (Berne et al., 
1998). With this high blood flow rate there most likely will be some toxic impact on these 
organs.  
 The adrenal cells are rich in lipid storages primary used for steroidogenesis. Due to this high 
lipid concentration lipophilic compounds might accumulate in this tissue, potentially causing 
a toxic effect on the steroid synthesis in the adrenal gland. Another way of toxically affecting 
the adrenal cells is through the metabolism of xenobiotic chemicals by the cytochrome P450 
enzymes, generating reactive compounds (Klaassen, 2001).   
1.1.1 Structure 
An outer cortex and an inner medulla, derived from embryonic mesoderm and neural crest 
cells, respectively, build up the adrenal glands. The medulla is responsible for producing 
adrenaline and noradrenaline, also called catecholamines. These important stress hormones 
differ from the steroid hormones, derived from the cortex, in structure and function (Boron 
and Boulpaep, 2003). The cortex in turn is subdivided into three layers, which together make 
up 80-90% (Berne et al, 1998; Nussey and Whitehead, 2001) of the adrenal gland. Zona 
glomerulosa is the outermost layer of the cortex located in the direct vicinity of the capsule, 
which surrounds the adrenal gland. The following layer is the zona fasciculata, representing 
the wide midcortex. The cells of this layer are columnar in shape, forming long cords (fig 1) 
and contain a high number of vacuoles. Zona reticularis represents the innermost layer of the 
 6 
Fig 1. Location and internal structure of the 
adrenal gland (Boron and Boulpaep, 2003).  
cortex and contains a smaller number of lipid 
droplets than the zona fasciculata. These cells 
are instead of long cords oriented in a network 
fashion (Berne et al., 1998).  
 Even if cholesterol is the starting point for all 
of the adrenal cortex steroids these are not 
equally synthesised all over the cortex. 
Glucocorticoids and the androgens are produced 
in the fasciculata and reticularis layers, with the 
main glucocorticoid production located in zona 
fasciculata (Berne et al., 1998). Due to lack of 
expression of the enzyme 17α-hydroxylase 
(CYP17A1) in the zona glomerulosa, no cortisol 
or androgen formation takes place in this layer, 
only production of the mineralocorticoid 
aldosterone (Nussey and Whitehead, 2001). The 
zona fasciculata and zona reticularis on the 
other hand lack the enzyme 18-hydroxysteroid 
dehydrogenase (CYP11B2), which is needed for aldosterone production (Klaassen, 2001). 
1.1.2 Function of the adrenocortical hormones 
The glucocorticoids are named after their initial discovery in glucose regulation (Boron and 
Boulpaep, 2003). Cortisol and corticosterone belong to this group and are regarded as critical 
to life, due to their effect on the metabolism of carbohydrates and protein. In humans cortisol 
is considered to be the dominant glucocorticoid, although if this pathway should be blocked 
corticosterone may step in its place upholding necessary activity (Berne et al., 1998).  
 Cortisol is responsible for increased glucose concentrations in plasma. Some other functions 
that this steroid possesses are immunosuppressive and anti-inflammatory activity, modulation 
of the CNS and to serve as an influent of the metabolism of fat, calcium and bone (Berne et 
al., 1998; Boron and Boulpaep, 2003). 
 As the name of the mineralcorticoid implies these steroids are involved in the mineral 
regulation of the body. The most prominent of the mineralcorticoids is aldosterone, 
responsible for re-absorption of sodium mainly in the kidneys, but also in colon, salivary 
glands and sweat glands (Berne et al., 1998; Boron and Boulpaep, 2003). 
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 Androgens are the precursors to the sex steroids and they are mainly synthesised in the zona 
reticularis. The final conversion to testosterone and estradiol takes place in the peripheral 
tissues (Berne et al., 1998).  
 
1.2 Aldosterone production 
1.2.1 Angiotensin II activation 
Synthesis of aldosterone is influenced mainly by the renin-angiotensin system, which releases 
renin. This is a response to reduced perfusion pressure in the kidney or decreased Na+ 
delivery to the macula densa, which is a group of cells belonging to the juxtaglomerular 
apparatus in the kidney, responsible for salt regulation. Due to these signals renin is released 
into the bloodstream, cleaving the precursor angiotensinogen, produced by the liver, to 
angiotensin I (Nussey and Whitehead, 2001; Berne and Levy, 1998). This peptide is cleaved 
into angiotensin II by the angiotensin-converting enzyme, located in the endothelial cells of 
the lungs or kidney (Nussey and Whitehead, 2001).  
1.2.2 Angiotensin II and ACTH induced signal transduction 
Angiotensin II (ang II) interacts with the glomerulosa cells in the adrenal gland by the AT1-
receptor, responsible for activation of phospholipase C (PLC) (fig 2). Due to this activation 
insitol 1,4,5-triphosphate (IP3) and sn-1,2-diacylglycerol (DAG) are formed. IP3 influences 
the intracellular calcium concentration by release from calcium stores and opening voltage-
dependent (T- and L-types) and calcium release activated (CRAC) channels (Capponi, 2004; 
Foster, 2004). DAG on the other hand activates the protein kinase C (PKC) pathway (Foster, 
2004). Calcium channels may also be opened by increases in K+ concentrations, which 
depolarize the cell membrane and activate voltage-dependent calcium channels without the 
need of internal Ca2+ release (Foster, 2004; Boron and Boulpaep, 2003). Since both ang II and 
potassium act by raising the calcium concentration they have a synergistic effect on the 
glomerulosa cells (Boron and Boulpaep, 2003).  
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Fig 2. Different pathways in the induction leading to aldosterone formation, based on information 
from Foster, 2004. ERK – a mitogen-activated protein kinase, MEK – mitogen-activated protein 
kinases kinase. Dotted arrows indicate possible signaling pathways and regulators.  
 
 Adrenocorticotropin hormone (ACTH) also stimulates aldosterone synthesis, although with 
less effect compared to ang II and K+. ACTH acts through another signaling pathway and 
binds a different G-protein-coupled receptor on the glomerulosa cell surface, thereby 
activating the formation of cAMP. cAMP in turn activates cAMP-dependent protein kinase A 
(PKA) (Foster, 2004; Boron and Boulpaep, 2003). PKA phosphorylates a number of proteins 
in the cytosol, which finally leads to Ca2+-influx across the plasma membrane (Boron and 
Boulpaep, 2003). Forskolin, which is an adenylate cyclase activator, has been used to mimic 
ACTH in cellular experiments with steroidogenic induction (Romero et al., 2004).  
 The end result of the signal transduction pathways is an induction of aldosterone secretion 
through for example phosphorylation of the steroidogenic acute regulatory (StAR) protein 
(Foster, 2004) and above all, through increased expression of steroidogenic genes.  
1.2.3 Gene regulation of genes involved in aldosterone formation 
Transcription of the genes involved in aldosterone formation is regulated based on the 
signaling pathways activated by ang II, potassium or ACTH described above. These 
modulators influence the gene expression levels differently based on which cell type that is 
influenced. For example CYP11B1 has a higher expression level in mainly fasciculata but also 
to some extent in the reticularis cells and is regulated by ACTH. CYP11B2 on the other hand 
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is highly expressed in the glomerulosa cells and is induced by ang II or potassium (Lisurek 
and Bernhardt, 2004; Basset et al., 2004). 
 ACTH conducts its activation through cAMP signaling (Foster, 2004) and it has been shown 
that treatment with cAMP analogues preferentially enhances CYP11B1 mRNA expression 
compared to CYP11B2. Even if it has been established that ACTH may cause an acute 
increase in aldosterone production it has also been recognized that it acts as an inhibitor on 
CYP11B2 expression after chronic exposure (Basset et al., 2004). It is not clear how this 
chronic exposure inhibit CYP11B2 expression, but it has been shown that cAMP has a 
negative effect on the expression of AT1R in glomerulosa cells. In contrast to the ACTH 
pathway, ang II and potassium act through a calcium intracellular signal, conducted by 
calcium binding proteins (Basset et al., 2004). The end result of the different signaling 
pathways described here is the transcription of target genes, based on activation of gene 
specific transcription factors.  
 Many of the binding sites in the promoter region are common among the CYPs involved in 
the steroid synthesis. Ad1, a cAMP response element (CRE), in humans and Ad4 are 
necessary for cAMP-induced and basal transcription, respectively, in the case of CYP11B1 
(Basset et al., 2004). Ad4 is known to bind the steroidogenic factor-1 (SF-1) (Basset et al., 
2004), which only seems to be present in the cells responsible for steroid synthesis (Omura 
and Morohashi, 1995). This factor regulates all genes except CYP11B2. 
 CYP11B2 is, in many cases, similar to the other enzymes involved in the steroid synthesis 
when it comes to the promoter region, with an Ad4 and a CRE site. But compared to 
CYP11B1 there are some sites that seem to be specific for this gene, Ad5 and a cis-element 
named NRBRE-1. These are able to bind two members of the NGFIB family of orphan 
nuclear receptors, NGFIB and NURRI. It has been suggested that these proteins play an 
important role in the regulation of CYP11B2. In a test with a reporter construct NGFIB 
together with NURRI activate the construct whereas SF-1 on its own did not. This indicates a 
different regulation of CYP11B2 compared to other genes involved in the steroid biosynthesis 
including StAR, CYP11A1, CYP11B1 and CYP17A1, which are all positively regulated by SF-
1 (Basset et al., 2004). 
1.2.4 Reaction pathways from cholesterol to aldosterone 
Cholesterol, which is the starting molecule for all steroid production of the adrenal cortex, is 
synthesised in the cytoplasm and stored in oil droplets within the cell (Omura and Morohashi, 
1995). The esterfied cholesterol must be transferred from the outer to the inner mitochondrial 
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membrane by StAR (Lumbers, 1999). The transport of cholesterol is the main rate-limiting 
step in all steroid hormone biosynthesis. Cleavage of cholesterol takes place in the internal 
mitochondrial matrix by the cholesterol side-chain cleavage cytochrome P450 (P450SCC or 
CYP11A1) (Foster, 2004; Rainey et al., 2004; Harvey and Everett, 2003). A schematic picture 
of the reaction pathways in steroid biosynthesis is presented in fig 3. 
 
 Transportation to the mitochondria 
  StAR ↓ 
 Cholesterol  17α-OH-Pregnenolone  DHEA  DHEA 
CYP11A1 ↓ ↓   CYP17A1 -sulfate   
 Pregnenolone Progesterone 3β-HSD  ↓ 
 3β-HSD   ↓ ↓   3β-HSD 
 Progesterone  17α-OH-Progesterone  Androstendione 
CYP21A2 ↓ ↓   CYP21A2  
 11-Deoxycorticosterone 11-Deoxycortisol  
CYP11B1 ↓ ↓   CYP11B1 
 Corticosterone Cortisol 
CYP11B2 ↓   
  Aldosterone   
 
Fig 3. Steroid biosynthesis in the adrenal cortex. Squared intermediates and enzymes are located in the 
mitochondrial membrane, non-marked are placed in the endoplasmatic reticulum (ER). 
Androstendione is transported from the cortex and transformed into either testosterone or estradiol in 
the gonads (Omura and Morohashi, 1995; Lisurek and Bernhardt, 2004; Rainey et al. 2004; Xu et al., 
2005). 
 
 The next step in aldosterone synthesis is the conversion of pregnenolone to progesterone. 
The enzyme responsible for progesterone formation is not a cytochrome P450 protein but 3β-
HSD (3β hydroxysteroid dehydrogenase type II, HSD3B2). 21-hydroxylase also known as 
CYP21A2 hydroxylates progesterone to 11-desoxycorticosterone, which is transported back 
to the mitochondria where it is hydroxylated by CYP11B1 (11β-hydroxylases) to 
corticosterone. CYP11B2 (aldosterone synthase) converts the product from CYP11B1 into 
aldosterone (Lumbers, 1999; Rainey et al. 2004).  
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1.3 Aldosterone action 
Aldosterone secreted by the adrenal gland has its main effect on the electrolyte transport 
across epithelial cells in mainly the kidney but also in salivary glands and colon. This has the 
effect of increasing the sodium and decreasing the potassium concentrations in the body and 
hence also saving the water from being excreted (White, 2003).  
 It has been noted that the mineralocorticoid receptor is expressed in the human heart. This 
indicates an effect of aldosterone directly on the heart and not only through the pressure effect 
that this mineralocorticoid possesses. The possible effect of aldosterone on the heart depends 
on which cell types that are affected and in which area of the heart (White, 2003). Since 
synthesis of aldosterone mainly takes place in the adrenal glands, but also in the heart, some 
interactions between these systems probably do exist. This means that higher levels of 
aldosterone production in the adrenal gland most likely affect the heart even if this is not the 
primary target (Hymes et al., 2004). 
 
1.4 Toxicity connected to the adrenal gland 
Aldosterone levels in the body can be raised through a number of different ways, not only by 
direct influence on the gene expression of involved enzymes and proteins in the steroid 
synthesis.  
 Some substances and compounds act through inhibition on the synthesized enzymes or other 
proteins in the steroid synthesis (Harvey and Johnson, 2002; Colby, 1981). Substances that 
possess this ability are represented in a number of groups, ranging from medical drugs to 
environmental toxins. These substances can act directly, or through their metabolite in order 
to inactivate the enzymes involved in steroidogenisis (Colby, 1981). For instance amino-
glutethimide inhibits CYP11A1, etomidate inhibits CYP11B1 and ketoconazole inhibits 
CYP17A1 (Harvey and Johnson, 2002). But it is not all substances that act through enzyme 
interactions, some substances may probably affect the gene expression of the involved genes. 
Because of this it is important to determine what effect these substances actually may have on 
the level of gene expression.  
1.4.1 Lead 
Lead has been recognized as a toxic metal since ancient times when Hippocrates first 
described abdominal colic in miners. The toxicity of this metal has even been proposed to be 
the cause of the fall of the Roman Empire, since the Romans utilized lead for a number of 
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food connected tools. Lead toxicity is characterized with anemia, neuropathy, nephropathy, 
sterility and coma (Papanikolaou et al., 2005) as well as affecting the blood pressure. Toxic 
effects of lead also affect the fetus with increased stillbirths, neonatal deaths as well as 
decreased fertility rate in exposed women (Needleman, 2004).  
 Lead is a divalent cation and it has the ability to mimic and/or compete with calcium. The 
competition may lead to inhibition of calcium entry of cells and swelling and distortion of 
mitochondrial cristea. Most of its toxicity can be connected to its ability of binding sulfhydryl 
groups on proteins, thereby deforming enzymes and structural proteins (Needleman, 2004). 
This is clearly shown in the heme synthesis with lead inhibiting three of the important 
enzymes involved, which decreases the concentration of circulating hemoglobin in the body 
(Papanikolaou et al., 2005). 
 Rat experiments have shown that twelve weeks of lead exposure increases blood pressure. 
Adrenal cells from lead-treated rats differ from controls, showing increased aldosterone 
secretion. The biosynthesis and excretion of corticosterone though still remained at the same 
level as in non-treated rats, indicating a lead effect specific for the later steps of aldosterone 
formation. It was proposed that lead affects the 18-oxidation performed by CYP11B2 
(Goodfriend et al., 1995).  
 
1.5 The H295R cell line 
The cell line called H295R originates from an adrenocortical carcinoma in a 48-year old black 
woman operated in the 1980s. The initial cell line from this carcinoma was named NCI-H295 
and was shown to express all of the enzymes that participate in normal human adrenal 
steroidogenesis. The cells also respond to the same secondary messengers, activating the 
genes coding for these enzymes, in the same fashion as normal adrenal cells (Rainey et al., 
2004). 
 There are a few substrains of the NCI-H295 cell line, derived by using different growth 
conditions in order to encourage substrate attachment and shorter cell cycle times. Compared 
to H295, which grow in suspension or in loosely attached patches, H295R and H295A grow 
more attached to the surface in a monolayer (Rainey et al., 2004).  
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1.6 Aim of project 
The aim of this project was to set up a model system based on the human adrenocarcionoma 
cell line H295R and to optimize the experimental conditions. This system will make it 
possible to determine the effects various substances have on gene expression of the involved 
enzymes and transport proteins in aldosterone formation.  
 Aldosterone is produced in the glomerulosa cells of the adrenal gland. The H295R-cells 
were due to this be exposed to ang II and potassium acetate (KAc) in order to differentiate 
these cells towards glomerulosa like cells. In addition different time intervals for 
differentiation of the cells were tested in order to find the most appropriate one. 
 There may be cytotoxic effects on the cells at some concentrations of the tested substances. 
Therefore proliferation tests were performed to establish a non-cytotoxic concentration. It was 
also possible that Ultroser SF (serum replacement) supplementation in the medium had an 
effect on cell differentiation or gene expression response, therefore this was tested as well.  
 Lead has been recognized to activate aldosterone formation in the adrenal gland. This was 
investigated in this project by determine if there were any differences in gene expression 
levels of the involved genes.  
 In all cases gene expression levels of the key enzymes and transporter proteins involved in 
the mineralocorticoid synthesis was established by quantitative real time-PCR (QRT-PCR).  
 
2. METHOD AND MATERIAL 
2.1 Chemicals and cell culture 
H295R cells can be commercially obtained from American Type Culture Collection 
(Rockville, MD, USA), in our case we have been given cells from Ingvar Brandt, Department 
of Physiology and Developmental biology, Uppsala university, Uppsala, Sweden. The cells 
were cultured in Gibco DMEM-F12 (1:1) medium (Invitrogen, Carlsbad, CA, USA) 
supplemented with 1% ITS PLUS culture supplement (BD Biosciences, Bedford, MA, USA), 
1% 5000 U/ml penicillin and 5000 µg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) and 
2% of the serum replacement Ultroser SF (USF) (Soprachem, France). Cells were grown in 
37oC with 5% CO2 and was passaged every seventh day with Gibco Trypsin-EDTA (1x) 
(Invitrogen, Carlsbad, CA, USA). Human angiotensin II was obtained from SIGMA (Saint 
Louis, MO, USA), forskolin from SIGMA, potassium acetate from BDH (now Merck KGaA, 
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Darmstadt, Germany), lead (II) acetate from SIGMA-Aldrich (Saint Louis, MO, USA) and 
staurosporin from SIGMA (Saint Lousi, MO, USA).  
2.2 Exposure and test of cell proliferation 
2.5 ml of a medium-cell suspension with the concentration of 200 000 cells/ml were seeded in 
6-well plates and 100 µl in a 96-well plate, all at 37oC in a humidified, 5% CO2 atmosphere. 
Cells were grown in the incubator for three days, where after the medium was changed to 
medium containing the test substance Depending on exposure setup different modulators for 
differentiation towards glomerulosa like cells was used for different time points. The cells 
were tested with ang II and KAc with the most efficient inducer tested for optimal induction 
time. The inducer was also tested with and without USF supplementation, as well as how the 
cells responded to different concentrations of lead. The medium was after exposure 
withdrawn and stored in -20oC for future analysis and the remaining cells were harvested 
from the 6-well plates with lysis buffer according to manual from the NucleoSpin® RNA II 
Kit (Clontech, Mountain View, CA, USA). The harvested cells were stored in -70oC until the 
day of use. 
 The 96-well plate was used for proliferation/toxicity test. 20 µl of CellTiter 96® AQueous 
One Solution Reagent (Promega corporation, Madison, WI, USA) was added to each well of 
cells at the same time as the 6-well plates were harvested after exposure. The CellTiter 96® is 
a MTS reduction test, wherein a tetrazolium compound is transformed to formazan by the 
cells. After incubation at the previous conditions for one hour each well was recorded for the 
absorbance at 490 nm utilizing Wallac Victor2, 1420 Multilabel counter (PerkinElmer life and 
Analytical sciences, Inc., Wellesley, MA, USA). The absorbance at 490 nm is directly 
proportional to the number of living cells in the culture. Staurosporine at the concentration of 
1µM was used as a positive control for toxicity in the 96-well plate. 
 
2.3 RNA isolation and quantitation 
Total RNA was isolated from the cells utilizing NucleoSpin® RNA II Kit (Clontech, 
Mountain View, CA, USA) following manufactures instructions. Basically the cells were 
lysed in the 6-well plates, if the RNA was not purified directly it was stored in -70oC until the 
day of use. 70% ethanol was added to the samples and the fluid was transferred to 
NucleoSpin® columns, where repeated washes and DNase I digestion took place. The RNA 
was eluted in nuclease-free water. Samples were stored at -70oC until use.  
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 RiboGreen® RNA-Specific Quantitation Kit with DNase I (Invitrogen, Carlsbad, CA, USA) 
was used to determine the concentration of the isolated RNA samples. Manufactures 
instructions were followed during the procedure. Since the samples already had been treated 
with DNase this step was omitted and a volume of 40 µl sample were generated by mixing 1 
µl RNA (diluted 10x in nuclease-free water) with 39 µl TE buffer (10 mM Tris-HCl, 1mM 
EDTA, ph 7,5). Each sample and RNA standard solution was later measured in duplicates. 
RiboGreen® reagent was added to each well and incubation took place at 37oC for 30 
minutes. Measurement of the 96-well plate was performed in Wallacs Victor2 at ~520 nm. 
The RNA concentrations were calculated based on the generated standard curve.  
 
2.4 cDNA-synthesis and RT-PCR amplification 
Reverse-iT™ 1st Strand Synthesis Kit (ABgene House, UK) was used according to protocol 
to synthesize cDNA from the purified total RNA. 1 µg RNA was mixed with random decamer 
primer (400 ng/µl), heated to 70oC to remove secondary structure and mixed with an solution 
of 5x First Strand Synthesis buffer, dNTP mix (0.2 nM final concentration), Reverse-iT™ 
RTase Blend and DTT (4 mM). Synthesis took place during 47oC-incubation for 50 minutes 
and the enzyme was deactivated by 75oC for 10 minutes. cDNA-samples were diluted to a 
final volume of 100 µl and stored at -20oC until the day of use. 
ABgenes Absolute™ QPCR Mix (ABgene House, UK) was used and mixed according to 
manufacturers instructions. The protocol shortly has the following procedure: A mix of 
Absolute™ QPCR Mix, gene specific forward (0.4 µM) and reverse (0.4 µM) primers, 
hybridization probes (0.1 µM) and nuclease-free water is put together to a final volume of 20 
µl. Template is added to this reaction mixture at a volume of 5 µl cDNA corresponding to 
<50ng RNA/reaction. 
 A Rotor-GeneTM 3000 (Corbett life science, Sidney, Australia) was used for QRT-PCR 
measurements. Amplification of cDNA was done by 15 minutes enzyme activation at 95oC, 
followed by 40 cycles of 15 seconds denaturation at 95oC and 1 minute of 
annealing/extension at 60oC. Primers used in the reactions were designed to anneal to the 
genes of the enzymes according to table 1. Detection of amplified products was done by gene 
specific Taqman probes, labeled: 5’-FAM and 3’-TAMRA. Two non-template controls were 
included in each run. The QRT-PCR program generated a standard curve based on five 
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known concentrations of the genes ranging from 102 – 106 copies, added in duplicate. This 
standard curve was used to calculate the copy number for each gene in the samples.  
 
Table 1. Sequence information of human primers and probes utilized in the QRT-PCR.  
Gene Forward primer Reverse primer Probe 
StAR TTGCTTTATGGGCTCAAGAATG GGAGACCCTCTGAGATTCTGCTT CATGCGCTGGCAGTACATGTGCAC 
CYP11A1 CTTCTTCGACCCGGAAAATTT CCGGAAGTAGGTGATGTTCTTGT CCCAACCCGATGGCTGAGCAA 
CYP17A1 GCTGACTCTGGCGCACACT CCATCCTTGAACAGGGCAAA TCGCCAGCCTTCGATGCAGCT 
HSD3B2 GCGGCTAATGGGTGGAATCTA CCTCATTTATACTGGCAGAAAGGAAT TGATACCTTGTACACTTGTGCGTTAAGACCCA 
CYP21A2 TCCCAGCACTCAACCAACCT CAGCTCAGAATTAAGCCTCAATCC CTCCCTTCCTGACCCTCCGCTGC 
CYP11B1 TCCCGAGGGCCTCTAGGA GGGACAAGGTCAGCAAGATCTT TGCTGCTTAGCCTGGCAAACCCTG 
CYP11B2 TTGTTCAAGCAGCGAGTGTTG GCATCCTCGGGACCTTCTC TCCTCTGCTTCCTGAGCTGTCCCCT 
SULT2A1 CCTCCAGCGGTGGCTACA AATCGTCCGACATGATGATGAC TTGAAACCCTCACACCACGCAGGA 
β-actin AGCCTCGCCTTTGCCGA CTGGTGCCTGGGGCG CCGCCGCCCGTCCACACCCGCC 
 
 The copy numbers of each gene for each exposure was calculated in Microsoft Excel 2003 
to generate diagrams visualizing possible effects on gene expression. The levels of β-actin 
were gathered from each sample, if normalization of the expressed genes should be needed.  
 Statistical testing was performed by StatView 5.0.1 (SAS Institute, Cary, NC, USA) to 
determine if there were any significant effects on the cells compared to the control. Kruskal-
Wallis and Mann-Whitney U tests were utilized in the statistical testing, which both are non-
parametric tests.  
 
3. RESULTS 
3.1 Proliferation/toxicity tests 
3.1.1 Proliferation effect on cells exposed to ang II or KAc 
The result of the proliferation/toxicity assay after ang II and potassium exposure is shown in 
fig 4. Staurosporine was used as a positive control, inhibiting proliferation, the negative 
control in this case was water. KAc was shown to have a significant stimulatory effect on cell 
proliferation at the two lowest concentrations, 1 mM and 10 mM. The highest concentration 
of ang II (100nM) was also significantly different in cell proliferation compared to the 
control, with higher proliferation level. Staurosporine on the other hand had a negative impact 
on cell proliferation, as expected. In the case of the highest concentration of KAc there were 
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fewer cells in these wells compared to the wells of the other two concentrations. Even if there 
is no difference in proliferation, this does not rule out a cytotoxic effect on the cells.  
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Fig 4. The result of the proliferation/toxicity assay after ang II and potassium exposure. Results 
expressed as mean ± SD; n = 5; p < 0.05 (marked with *). Statistical testing was performed with Mann 
Whitney U.  
 
3.1.2 Test if USF addition has any effect on cell proliferation 
This test was performed to determine if cell proliferation was influenced by USF 
supplementation in the medium. The result of the proliferation assay is presented in fig 5. 
When cells were exposed to ang II in USF supplemented (USF+) medium, small stimulatory 
effects on proliferation was noted. This was not the case in medium without USF (USF-) 
where the increasing concentrations of ang II had a negative effect on the cells, clearly 
notable as dead cells in the wells. This was not noted with the same concentrations in the 
exposure wells, where the cells seemed to proliferate just like the cells in USF+ medium. The 
decrease in proliferation in the absence of USF has however not been able to be reproduced 
(see discussion).  
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Fig 5. The proliferation/toxicity assay results with four different ang II concentrations in USF+/- 
medium. * indicate a p-value < 0.05 compared to the control. USF+, ang II 1000 nM is based on four 
absorbance values (indicated with “a”) instead of five as the rest.  
 
3.1.3 Test if lead exposure has any effect on cell proliferation in USF+ medium 
In order to test the model system lead was chosen as test substance, since it has a known 
effect on aldosterone synthesis in the adrenal gland. The proliferation/toxicity effect of this 
exposure is shown in fig 6. Some effects on proliferation seem to be present in the lowest 
concentration of lead without ang II supplementation, and in the highest concentration of lead 
with ang II supplementation, according to statistical analysis. Both cases have a negative 
effect compared to the control, but these differences are not big.  
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Fig 6. Proliferation/toxicity test of lead exposure to cells in USF+ medium. * indicate a p-value < 0.05 
compared to the corresponding control. Each concentration and control is based on 5 measurements. 
Statistical analysis was performed with Mann Whitney U.  
 
3.1.4 Effect of lead exposure to cell proliferation without USF supplementation 
The proliferation/toxicity tests for lead exposure in medium without USF showed no 
significant toxic effects on the cells with ang II addition. Some differences in viability 
compared to cells in USF+ medium can be noted. In this case there is a higher level of 
viability for the cells treated without ang II compared to the same setup in USF+ medium. 
Since the previous proliferation assay for this particular comparison (fig 5) may be misleading 
it is hard to tell if the difference noted here is consistent or not.  
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Fig 7. Proliferation/toxicity test of lead exposure in medium without USF. * indicate a p-value < 0.05 
compared to the corresponding control and each test has been repeated five times. Analysis was 
performed with Mann Whitney U. 
 
 
3.2 Quantitative RT-PCR analysis 
3.2.1 Determination of optimal concentrations of modulator for gene induction 
Ang II induction was most notable detectable by the level of CYP11B2 expression. High 
expression levels of this gene were also noted with KAc treatment. This is expected since ang 
II and potassium is recognized as the inducers of aldosterone formation and hence activation 
of this specific gene. The expression levels for all genes declined at the highest concentration 
of KAc through out the experiment. This corresponded with the results from the proliferation 
test, indicating a small decrease in proliferation compared to the other concentrations of KAc. 
Ang II on the other hand showed increasing gene induction following higher concentrations 
for many of the involved genes, see fig 8.  
 Forskolin was used as a control and showed expected effects, with high induction of 
CYP17A1 and CYP11B1, two important enzymes involved in cortisol formation. 
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Fig 8. QRT-PCR result for the induction test with KAc and ang II in USF+ medium. The relative gene 
expression levels for forskolin, KAc and ang II induction expressed as mean ± SD; n=3; p < 0.05 (in 
comparison with the vehicle, indicated with *).  The vehicle control is equal to one but not shown in 
the figure.  
 
 Since induction with ang II 100 nM did not show any toxic effects and gave the highest 
level of gene expression for genes like CYP11B2 and CYP11B1 this concentration was chosen 
for the following experiments.  
3.2.2 Test of induction time with 100 nM of ang II 
The cells were exposed to 100 nM ang II for 8 h, 24 h, 48 h and 72 h before harvest. This was 
done in order to determine if there was a time point more suitable for ang II induction. The 
results from the QRT-PCR on this experiment are shown in fig 9. No preferred time for ang II 
induction is indicated after this experiment. The only genes that were affected due to 
differences in time with ang II induction according to Kruskal-Wallis analysis were HSD3B2 
and SULT2A1. Differences between the time points for HSD3B2 expression were only 
significant between 24 h and 48 h and between 48 h and 72 h for the ang II treatment. There 
were also a significant difference in gene expression of HSD3B2 for the control between 8 h 
and 24 h. In the case of SULT2A1 there were significant differences in gene expression levels 
between all time points, 8-24 h, 24-48 h and 48-72 h. There were also significant differences 
in gene expression levels for this gene between 24-48 h of the control. Kruskal Wallis 
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analysis was also performed for the controls and CYP17A1, CYP21A2, CYP11B2 and 
SULT2A1 were considered significant in this case.  
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Fig 9. The QRT-PCR results for the time-induction test in USF+ medium shown in relative expression 
levels ± SD compared to the H2O control (equal to one, but not present). The results are based on 
triplicates and the asterisks indicate p < 0.05 in comparison with the control, based on Mann Whittney 
U-analysis. No gene expression differences between the time points were noted with ang II induction 
based on Kruskal Wallis analysis, except for the expression levels of HSD3B2 and SULT2A1.  
 
3.2.4 Effect on gene expression based on USF supplementation in medium 
The cells were exposed to ang II at the concentrations of 100 and 1000 nM with and without 
USF in the medium. This was done to determine if serum supplementation has an effect on 
gene expression levels. It was noted that there was a significant difference in gene expression 
due to USF supplementation, for all genes except CYP11A1 for the control. In the comparison 
between the ang II samples in USF+ and USF- medium it was established that a significant 
difference in gene expression were present for all genes except CYP11A1 in the 100 nM 
concentration and CYP11A1 and SULT2A1 in the 1000 nM concentration. HSD3B2 was the 
gene that differed most in relative expression levels between the USF+ and USF- mediums, 
which is clearly visible in fig 10.  
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Fig 10. This is all of the data from the USF supplementation test based on triplicate values. The 
relative expression level for HSD3B2 in USF- medium is extremely high. * indicates p < 0.05 (in 
comparison to the related control). There is a corresponding control without ang II for the USF+ as 
well as for the USF- exposure, both are set to 1.0 in this figure (although not present). 
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Fig 11. The same data as in fig 10 but the values for HSD3B2 in medium without USF has been 
excluded in order to visualize the expression levels of the other genes. * indicates p < 0.05 (compared 
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to the related control). There is a corresponding H2O-control for the USF+ as well as for the USF- 
exposure, both set to 1.0 in this figure (although not present). 
3.2.4 Test of lead exposure to cells grown in USF+ medium 
Shown in fig 12 are the results from the QRT-PCRs on the lead exposure in USF+ medium. 
Lead is known to increase aldosterone formation and we were hoping to find gene regulation 
effects based on this. The final conclusion is that no lead specific effects can be detected on 
the gene expression level except for a few genes, which have been marked in the figure. 
These effects may on the other hand be incidental due to a high number of comparisons.  
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Fig 12. Relative gene expression levels for lead treatment in USF+ medium. Results are expressed as 
mean ± SD; n = 3; p < 0.05 (in comparison with the control, indicated with *). The H2O-control as 
well as the ang II-control in this case are equal to 1.0 and have been excluded from the figure. Mann 
Whitney U was utilized for statistical analysis.  
3.2.5 Test of lead exposure to cells grown without USF supplementation 
The same setup was used in this test as the previous one with lead, except for no addition of 
USF to the medium. The outcome of this exposure did not turn out much different from the 
previous one except for some indications of lead effects in cells treated without ang II. The 
QRT-PCR results indicate that StAR, CYP11A1 and CYP21A2 are down regulated in a 
concentration dependent manner and that CYP11B2 in fact is up regulated. These effects are 
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not present in the ang II-induced cells. Genes that are differently expressed in comparison to 
the corresponding control has been marked with an asterisk in fig 13.  
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Fig 13. Lead induction without USF supplementation in relative gene expression levels. Results are 
expressed as mean ± SD; n = 3; p < 0.05 (in comparison with the control, indicated with *). There 
were one control with H2O and one control with ang II, these have been left out in this figure but are 
both equal to 1.0. Statistical analysis was performed by Mann Whitney U. 
 
 
4. DISCUSSION 
The purpose of this project was to utilize the H295R-adrenocarcinoma cell line in order to 
generate a system for determining the effects various substances have on the aldosterone 
production and gene expression of the involved enzymes and transport protein.  
 The cells were supposed to be differentiated into glomerulosa like cells using angiotensin II 
or potassium. The up- or down-regulation effects on the gene expression were determined 
utilizing quantitative real time PCR (QRT-PCR). Aldosterone secretion will later be 
determined using radioimmunoassay and therefore medium from the exposures has been 
stored for future analysis. 
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4.1 Modulators of differentiation towards aldosterone producing cells 
Induction with angiotensin II (ang II) and potassium is considered to be a way of 
differentiating H295R cells into glomerulosa like cells. It is expected to find genes that are 
involved in the aldosterone synthesis are up-regulated to a higher extent than genes associated 
with for instance cortisol production, which is usually activated in the fasciculata cells. The 
first test that was performed was done in order to determine if ang II or potassium is the best 
inducer in this case. As can be seen in fig 4 there seem to be toxic effects on the cells at the 
concentration of 100 mM KAc, since the proliferation decreases in this case. The cells were 
notably fewer at this concentration prior to harvest and as can be seen in the diagram from the 
QRT-PCRs, the gene expression for the involved genes are also lower. Since the same amount 
of RNA was used for each sample in the cDNA synthesis the explanation for the lower 
expression levels of these genes cannot be a smaller amount of total RNA.  
 Forskolin is more associated with cortisol induction, since it mimics ACTH activation, and 
should in this case provide a lower expression level for CYP11B2-mRNA than ang II. As can 
be seen in fig 8 there is a twice as high induction of CYP11B2 expression with ang II 
compared to forskolin, indicating a differentiation difference between the two modulators. 
Another proof of the difference in gene induction between forskolin and ang II is the raised 
levels of CYP11B1 and CYP17A1 expressions (clearly notable in fig 8) with forskolin 
induction, these genes are utilized in cortisol formation. 100 nM ang II was chosen for 
differentiation of the H295R-cells into glomerulosa-like cells and for induction of aldosterone 
production. Ang II was chosen over KAc due to higher levels of gene expression and the fact 
that high concentrations of KAc seemed to be cytotoxic.  
 
4.2 Determining angiotensin II induction times 
By inducing the cells for different time intervals it was possible to determine an appropriate 
time for ang II induction before exposure experiments took place. As can be seen in fig 9, 
there do not seem to be any differences in gene expression if the ang II induction continues 
for 8 hours or 72. This was confirmed with Kruskal Wallis analysis, where it was indicated 
that time had less effect on the gene expression with ang II compared to without. HSD3B2 
and SULT2A1 where the only genes that were significantly different in gene expression over 
time due to ang II-induction. Except for these genes there seem to be no preferred time in this 
case, therefore ang II induction was set to 24 hours due to convenience. 
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4.3 Ultroser SF supplementation or not during exposure 
Ultroser SF (USF) is a substitute for human serum. In serum there are a number of known as 
well as unknown substances. Most cells are considered to need serum addition for efficient 
growth. In this case we wanted to determine if a serum addition made any difference to the 
ang II differentiation towards glomerulosa like cells or not. The comparisons between USF 
supplemented cells and non-supplemented are shown in fig 5, 10 and 11. As can be seen in fig 
5 there seem to be significant toxic effects of ang II addition in the concentrations of 10 and 
100 nM in USF- medium. This phenomenon is not reproducible and could not be noted in the 
6-well plates exposed at the same time. The total yield of RNA from the 6 wells plates 
without USF was generally the same as for the control and those with an addition of USF.  
  As can be seen in the diagrams from the QRT-PCRs (fig 10 and 11) there indeed is a 
difference between ang II induction in USF+ (lower gene expression levels) and USF- 
medium (higher gene expression levels for some genes). These USF-coupled differences are 
noted in proliferation as well as in gene expression levels and have been shown to be 
significant. The explanation for this is not clear and these differences will require more 
investigation.  
 The basal level of HSD3B2 and CYP21A2 are notably lower in the non-USF-supplemented 
cells, therefore the fold induction of these genes after ang II induction seem to be higher 
compared to the levels in the USF supplemented cells (data not presented). The expression of 
SULT2A1 is extremely high in the cells grown without USF. Together with the results from 
CYP21A2 and HSD3B2 expression it is interesting to note that the cells grown in USF- seem 
to mimic the adrenal steroid synthesis in fetuses. Rehman et al. (2003) showed that the 
transcription level of HSD3B2 was 127-fold higher in the adult adrenal compared to the fetal, 
with the levels in the fetal barely detectable. The transcription levels of SULT2A1 were on the 
other hand 13-fold higher in the fetal adrenal compared to the adult. The reason for this is that 
the adrenal cells in the fetus have another role than they do in the adult, with hormone 
synthesis focusing on androgens during development and gluco- and mineralocorticoids in the 
adult (Rehman et al., 2003), which explains the different expression pattern. The results noted 
here do not indicate that serum depletion differentiated the H295R into fetal-like cells, to 
draw that assumption we need to do more investigations.   
 Statistical analysis indicates a significant difference in gene expression levels for a number 
of genes. StAR, HSD3B2, CYP11B1, CYP11B2 and SULT2A1 for all concentrations of ang II 
with and without USF supplementation are all significantly different from the corresponding 
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control. StAR, HSD3B2, CYP11B1, CYP11B2 in these cases have a higher level of gene 
expression and SULT2A1 has a lower expression level.  
 Even CYP17A1 and CYP21A2 are significantly different in gene expression levels due to 
USF supplementation, except for one concentration of ang II in each case. The levels for 
CYP17A1 are lower for one ang II concentration in USF- and higher for both concentrations 
in USF+. CYP21A2 has a significantly higher level of gene expression in USF-, but have a 
level close to the control in USF+ except for one ang II concentration that is significantly 
higher.  
 The only gene that does not seem to be affected by USF supplementation is CYP11A1, 
which also do not differ from the expression levels of the control. It would be interesting to 
see if the increased gene expression levels of CYP21A2 and CYP11B2 in USF- medium 
actually has had an effect on aldosterone secretion compared to cells treated with USF+ 
medium.  
 
4.4 Lead exposure 
The proliferation/toxicity tests did not indicate any lead toxicity that had to be taken into 
consideration, neither in USF+ nor in USF- medium (fig 6 and 7). The concentrations of lead 
determined to significantly have an effect on proliferation have not been excluded since the 
differences in proliferation is very small, even if they are statistically significant. 78% 
viability compared to the control was the lowest value calculated for the lead exposure test. 
 Lead exposure in USF+ medium did not provide any specific effects on gene expression. As 
can be seen in fig 12 there seem to be some genes that are statistically significant, but these 
can also be incidental results due to a high number of comparisons. Practically all genes are 
expressed at the same level as its corresponding control in the exposure with USF+. The only 
genes that differ from this are CYP11B1 and CYP11B2, which have higher expression levels. 
If this raised level of expression is due to the lead treatment or the effect of ang II is hard to 
tell.  
 In the case of lead exposure with USF- medium we have different patterns compared to the 
USF+. There do not seem to be any effects on gene expression when ang II treated cells are 
exposed to lead (fig 13), but this is not the case for the cells exposed only to lead. StAR, 
CYP11A1 and CYP21A2 seem to be down regulated in a concentration dependent fashion, 
CYP11B2 on the other hand seem to be up regulated.  
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 Lead exposure has been reported to induce aldosterone formation by a number of 
researchers, for example by Goodfriend et al. This also seems to be the case for H295R-cells 
grown in medium without USF and without ang II induction, based on gene expression levels. 
It has not been confirmed but the down regulation of the mentioned genes might be 
compensated for by the up regulation of CYP11B2. If this is the case aldosterone formation 
should not divert too much from the control in a test where the concentration of aldosterone 
secretion can determined. Aldosterone concentration determination has not been performed in 
this project. We will need to perform more lead exposures in order to determine if there is any 
biological significance in the differences noted here.  
 
 
5. CONCLUSIONS 
In this project the human H295R cell line was utilized as a model system for detection of 
effects on gene expression on steroid synthesis in the adrenal gland. This method has been 
optimized for angiotensin II induction in order to differentiate the cells towards glomerulosa 
like cells. The setup has been tested with lead, which is a known inducer of aldosterone 
formation.  
 The model will need more testing, in order to clarify that it fulfills the criteria for a workable 
model system in determination of steroidogenic gene expression effects. The different effects 
on steroid gene induction due to serum supplementation or not, will need some further 
investigation.  
 This model will need to be complimented by an assay that measures the concentration of 
secreted steroid products. This has to be done in order to establish if changes in gene 
expression can be correlated to changes in hormone secretion or not.  
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